JC Viruria Is Associated With Reduced Risk of Diabetic Kidney Disease.
暂无分享,去创建一个
C. Langefeld | K. Skorecki | J. Divers | B. Freedman | P. Hicks | D. Lyles | Etty Kruzel-Davila | G. Russell | Lijun Ma | Z. Kra-oz | Moran Szwarcwort Cohen | E. Kruzel-Davila
[1] C. Langefeld,et al. Protective association between JC polyoma viruria and kidney disease , 2019, Current opinion in nephrology and hypertension.
[2] C. Langefeld,et al. JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] K. Skorecki,et al. "Biomarking" the transition from genetic risk to kidney disease. , 2018, Kidney international.
[4] R. Do,et al. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants. , 2018, Kidney international.
[5] K. Skorecki,et al. APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story. , 2017, Seminars in nephrology.
[6] M. Buck,et al. APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8. , 2017, JCI insight.
[7] Patrick D. Dummer,et al. Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice , 2017, Nature Medicine.
[8] B. O'Hara,et al. JC Polyomavirus Infection of Primary Human Renal Epithelial Cells Is Controlled by a Type I IFN-Induced Response , 2016, mBio.
[9] Dermot F. Reilly,et al. Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort. , 2016, Journal of the American Society of Nephrology : JASN.
[10] Catherine C. Robertson,et al. Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects. , 2016, Journal of the American Society of Nephrology : JASN.
[11] Benjamin J. Keller,et al. Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND) , 2015, PLoS genetics.
[12] Sophie Limou,et al. APOL1 Kidney Disease Risk Variants: An Evolving Landscape. , 2015, Seminars in nephrology.
[13] M. Ramsay,et al. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans. , 2015, Journal of the American Society of Nephrology : JASN.
[14] V. D’Agati,et al. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1 , 2014, Kidney international.
[15] Nicholette D. Palmer,et al. APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes , 2014, Kidney international.
[16] K. Skorecki,et al. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[17] A. Rubio-Guerra,et al. Diabetic nephropathy and inflammation. , 2014, World journal of diabetes.
[18] R. Bosch,et al. Plasma apolipoprotein L1 levels do not correlate with CKD. , 2014, Journal of the American Society of Nephrology : JASN.
[19] J. Kopp. JC viruria and kidney disease in APOL1 risk genotype individuals: is this a clue to a gene × environment interaction? , 2013, Kidney international.
[20] M. Rocco,et al. JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy , 2013, Kidney international.
[21] A. Vallinoto,et al. Prevalence of infection by JC and BK polyomaviruses in kidney transplant recipients and patients with chronic renal disease , 2011, Transplant infectious disease : an official journal of the Transplantation Society.
[22] G. Genovese,et al. Population-based risk assessment of APOL1 on renal disease. , 2011, Journal of the American Society of Nephrology : JASN.
[23] J. O'Toole,et al. APOL1 localization in normal kidney and nondiabetic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.
[24] H. Anders,et al. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. , 2011, Kidney international.
[25] Giulio Genovese,et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[26] E. Major,et al. Inhibitory interactions between BK and JC virus among kidney transplant recipients. , 2011, Journal of the American Society of Nephrology : JASN.
[27] C. Winkler,et al. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.
[28] S. Rosset,et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.
[29] H. Anders,et al. Interferon-alpha and -beta in kidney inflammation. , 2010, Kidney international.
[30] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[31] Adrian Egli,et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. , 2009, The Journal of infectious diseases.
[32] B. O'Hara,et al. Invasion of Host Cells by JC Virus Identifies a Novel Role for Caveolae in EndosomalSorting of Noncaveolar Ligands , 2006, Journal of Virology.
[33] W. Knowles. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). , 2006, Advances in experimental medicine and biology.
[34] Kristina Doerries. Human polyomavirus JC and BK persistent infection. , 2006, Advances in experimental medicine and biology.
[35] W. Atwood,et al. The human polyomaviruses , 2006, Cellular and Molecular Life Sciences CMLS.
[36] G. Silvestri. Naturally SIV‐infected sooty mangabeys: are we closer to understanding why they do not develop AIDS? , 2005, Journal of medical primatology.
[37] R. Elston,et al. The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. , 2005, Journal of diabetes and its complications.
[38] A. Tenório,et al. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[39] P. Klapper,et al. Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[40] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[41] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[42] D. Pillay,et al. Prevalence of long‐term BK and JC excretion in HIV‐infected adults and lack of correlation with serological markers , 1999, Journal of medical virology.
[43] J. Cohen,et al. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. , 1993, The Journal of infectious diseases.
[44] T. Miyamura,et al. Prevalence Rate and Age of Acquisition of Antibodies against JC Virus and BK Virus in Human Sera , 1982, Microbiology and immunology.